Local and regional therapies are recommended for patients with hepatocellular carcinoma
(HCC) in very early (Barcelona Clinic Liver Cancer [BCLC] 0), early (BCLC A), and …

Hepatocellular carcinoma (HCC), one of the most common cancers worldwide, is often
diagnosed at an advanced stage when most potentially curative therapies such as resection …

Since the 1990s, oncolytic viruses were utilized to treat cancer patients from phase I to
phase III. Oncolytic virus development in China has been keeping in step with that in other …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide.
The major etiologies and risk factors for the development of HCC are well defined and some …

Killing of tumor cells by anticancer therapies commonly used in the treatment of cancer, eg
chemotherapy, γ-irradiation, immunotherapy or suicide gene therapy, is predominantly …

To clarify the pathogenesis of hepatocellular carcinoma (HCC) and investigate the effects of
potential therapies, a number of mouse models have been developed. Subcutaneous …

Purpose: Hepatocellular carcinoma (HCC) is one of the most common recurrent
malignancies, for which, currently, there is no effective therapy. Considering the …

Sulforaphane is a chemopreventive agent present in various cruciferous vegetables,
including broccoli. Here, we show that treatment with tumor necrosis factor (TNF)–related …

Hepatocellular carcinoma (HCC) is a common malignant tumor with insidious early
symptoms, easy metastasis, postoperative recurrence, poor drug efficacy, and a high drug …

Hepatocarcinogenesis is a complex multistep biological process involving genetic and
epigenetic alterations that are accompanied by activation of oncoproteins and inactivation of …